Mood disorders in inflammatory bowel disease: Relation to diagnosis, disease activity, perceived stress, and other factors

Inflammatory Bowel Diseases

Volumn 18, Issue 12, 2012, Pages 2301-2309

  Goodhand, J R ^a   Wahed, M ^a   Mawdsley, J E ^a   Farmer, A D ^a   Aziz, Q ^a   Rampton, D S ^a,b  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b ROYAL LONDON HOSPITAL   (United Kingdom)

Author keywords

anxiety; calprotectin; Crohn's disease; depression; inflammation; psychological stress; ulcerative colitis

Indexed keywords

C REACTIVE PROTEIN; CALGRANULIN;

ABDOMINAL PAIN; ADULT; AGED; ANXIETY; ANXIETY DISORDER; ARTICLE; CONTROLLED STUDY; CROHN DISEASE; DEPRESSION; DISEASE ACTIVITY; ENTERITIS; FEMALE; GASTROINTESTINAL ENDOSCOPY; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOOD DISORDER; MULTIVARIATE ANALYSIS; PERCEIVED STRESS QUESTIONNAIRE; PREVALENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUESTIONNAIRE; SOCIAL STATUS; STRESS; ULCERATIVE COLITIS;

ADULT; ANXIETY; CASE-CONTROL STUDIES; COLITIS, ULCERATIVE; CROHN DISEASE; CROSS-SECTIONAL STUDIES; DEPRESSION; FECES; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; LEUKOCYTE L1 ANTIGEN COMPLEX; MALE; MOOD DISORDERS; PSYCHIATRIC STATUS RATING SCALES; QUESTIONNAIRES; REGRESSION ANALYSIS; RISK FACTORS; STRESS, PSYCHOLOGICAL;

EID: 84869218485     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.22916     Document Type: Article

References (66)

1. Baumgart DC, Carding SR,. Inflammatory bowel disease: cause and immunobiology. Lancet. 2007; 369: 1627-1640.
2. Baumgart DC, Sandborn WJ,. Inflammatory bowel disease: clinical aspects and established and evolving therapies. Lancet. 2007; 369: 1641-1657.
3. Robertson DA, Ray J, Diamond I, et al. Personality profile and affective state of patients with inflammatory bowel disease. Gut. 1989; 30: 623-626.
4. Mikocka-Walus AA, Turnbull DA, Moulding NT, et al. Does psychological status influence clinical outcomes in patients with inflammatory bowel disease (IBD) and other chronic gastroenterological diseases: an observational cohort prospective study. Biopsychosoc Med. 2008; 2: 11.
5. Helzer JE, Chammas S, Norland CC, et al. A study of the association between Crohn's disease and psychiatric illness. Gastroenterology. 1984; 86: 324-330.
6. Addolorato G, Capristo E, Stefanini GF, et al. Inflammatory bowel disease: a study of the association between anxiety and depression, physical morbidity, and nutritional status. Scand J Gastroenterol. 1997; 32: 1013-1021.
7. Kovacs Z, Kovacs F,. Depressive and anxiety symptoms, dysfunctional attitudes and social aspects in irritable bowel syndrome and inflammatory bowel disease. Int J Psychiatry Med. 2007; 37: 245-255.
8. Kurina LM, Goldacre MJ, Yeates D, et al. Depression and anxiety in people with inflammatory bowel disease. J Epidemiol Commun Health. 2001; 55: 716-720.
9. Tarter RE, Switala J, Carra J, et al. Inflammatory bowel disease: psychiatric status of patients before and after disease onset. Int J Psychiatry Med. 1987; 17: 173-181.
10. Walker JR, Ediger JP, Graff LA, et al. The Manitoba IBD cohort study: a population-based study of the prevalence of lifetime and 12-month anxiety and mood disorders. Am J Gastroenterol. 2008; 103: 1989-1997.
11. Hauser W, Janke KH, Klump B, et al. Anxiety and depression in patients with inflammatory bowel disease: comparisons with chronic liver disease patients and the general population. Inflamm Bowel Dis. 2011; 17: 621-632.
12. Filipovic BR, Filipovic BF, Kerkez M, et al. Depression and anxiety levels in therapy-naive patients with inflammatory bowel disease and cancer of the colon. World J Gastroenterol. 2007; 13: 438-443.
13. Magni G, Bernasconi G, Mauro P, et al. Psychiatric diagnoses in ulcerative colitis. A controlled study. Br J Psychiatry. 1991; 158: 413-415.
14. Helzer JE, Stillings WA, Chammas S, et al. A controlled study of the association between ulcerative colitis and psychiatric diagnoses. Dig Dis Sci. 1982; 27: 513-518.
15. Mardini HE, Kip KE, Wilson JW,. Crohn's disease: a two-year prospective study of the association between psychological distress and disease activity. Dig Dis Sci. 2004; 49: 492-497.
16. Mittermaier C, Dejaco C, Waldhoer T, et al. Impact of depressive mood on relapse in patients with inflammatory bowel disease: a prospective 18-month follow-up study. Psychosom Med. 2004; 66: 79-84.
17. Persoons P, Vermeire S, Demyttenaere K, et al. The impact of major depressive disorder on the short- and long-term outcome of Crohn's disease treatment with infliximab. Aliment Pharmacol Ther. 2005; 22: 101-110.
18. Deter HC, Scheidt CE,. [Attachment and development within psychosomatic medicine.] Psychother Psychosom Med Psychol. 2008; 58: 303.
19. Levenstein S, Prantera C, Varvo V, et al. Stress and exacerbation in ulcerative colitis: a prospective study of patients enrolled in remission. Am J Gastroenterol. 2000; 95: 1213-1220.
20. Bitton A, Dobkin PL, Edwardes MD, et al. Predicting relapse in Crohn's disease: a biopsychosocial model. Gut. 2008; 57: 1386-1392.
21. Bernstein CN, Singh S, Graff LA, et al. A prospective population-based study of triggers of symptomatic flares in IBD. Am J Gastroenterol. 2010; 105: 1994-2002.
22. Duffy LC, Zielezny MA, Marshall JR, et al. Relevance of major stress events as an indicator of disease activity prevalence in inflammatory bowel disease. Behav Med. 1991; 17: 101-110.
23. Bitton A, Sewitch MJ, Peppercorn MA, et al. Psychosocial determinants of relapse in ulcerative colitis: a longitudinal study. Am J Gastroenterol. 2003; 98: 2203-2208.
24. Graff LA, Walker JR, Bernstein CN,. Depression and anxiety in inflammatory bowel disease: a review of comorbidity and management. Inflamm Bowel Dis. 2009; 15: 1105-1118.
25. Mikocka-Walus AA, Turnbull DA, Moulding NT, et al. Controversies surrounding the comorbidity of depression and anxiety in inflammatory bowel disease patients: a literature review. Inflamm Bowel Dis. 2007; 13: 225-234.
26. Levenstein S, Prantera C, Varvo V, et al. Psychological stress and disease activity in ulcerative colitis: a multidimensional cross-sectional study. Am J Gastroenterol. 1994; 89: 1219-1225.
27. Angelopoulos NV, Mantas C, Dalekos GN, et al. Psychiatric factors in patients with ulcerative colitis according to disease activity. Eur J Psychiatry. 1996; 87-99.
28. Lix LM, Graff LA, Walker JR, et al. Longitudinal study of quality of life and psychological functioning for active, fluctuating, and inactive disease patterns in inflammatory bowel disease. Inflamm Bowel Dis. 2008; 14: 1575-1584.
29. Porcelli P, Leoci C, Guerra V,. A prospective study of the relationship between disease activity and psychologic distress in patients with inflammatory bowel disease. Scand J Gastroenterol. 1996; 31: 792-796.
30. Isgar B, Harman M, Kaye MD, et al. Symptoms of irritable bowel syndrome in ulcerative colitis in remission. Gut. 1983; 24: 190-192.
31. Simren M, Axelsson J, Gillberg R, et al. Quality of life in inflammatory bowel disease in remission: the impact of IBS-like symptoms and associated psychological factors. Am J Gastroenterol. 2002; 97: 389-396.
32. Minderhoud IM, Oldenburg B, Wismeijer JA, et al. IBS-like symptoms in patients with inflammatory bowel disease in remission; relationships with quality of life and coping behavior. Dig Dis Sci. 2004; 49: 469-474.
33. Mawdsley JE, Jenkins DG, Macey MG, et al. The effect of hypnosis on systemic and rectal mucosal measures of inflammation in ulcerative colitis. Am J Gastroenterol. 2008; 103: 1460-1469.
34. Mawdsley JE, Macey MG, Feakins RM, et al. The effect of acute psychologic stress on systemic and rectal mucosal measures of inflammation in ulcerative colitis. Gastroenterology. 2006; 131: 410-419.
35. Wahed M, Goodhand JR, Langmead FL, et al. Anxiety and psychological stress in acute severe ulcerative colitis: prevalence and effect on outcome. Gastroenterology. 2011; 140: S60-61.
36. Wahed M, Smith M, Langmead FL, et al. Hypnotherapy for the prevention of relapse in ulcerative colitis: a multicentre, randomised, single-blind, controlled clinical trial. Gut UEGW. 2011.
37. Goodhand JR, Wahed M, Lindsay JO, et al. True IBS is uncommon in Crohn's disease: IBS symptoms imply active disease. Gut. 2009; 58 (Suppl II): A320.
38. Farmer AD, Coen SJ, Kano M, et al. Phenotyping pain in health and disease. Neurogastroenterol Motil. 2010; 22 (Suppl 1): 5.
39. ACORN. www.caci.co.uk/acorn-classification.aspx Accessed February, 2011.
40. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis. 1987; 40: 373-383.
41. Silverberg MS, Satsangi J, Ahmad T, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol. 2005; 19 (Suppl A): 5-36.
42. Walmsley RS, Ayres RC, Pounder RE, et al. A simple clinical colitis activity index. Gut. 1998; 43: 29-32.
43. Baron JH, Connell AM, Lennard-Jones JE,. Variation between observers in describing mucosal appearances in proctocolitis. Br Med J. 1964; 1: 89-92.
44. Best WR, Becktel JM, Singleton JW, et al. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology. 1976; 70: 439-444.
45. Zigmond AS, Snaith RP,. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983; 67: 361-370.
46. Levenstein S, Prantera C, Varvo V, et al. Development of the Perceived Stress Questionnaire: a new tool for psychosomatic research. J Psychosom Res. 1993; 37: 19-32.
47. Tibble JA, Sigthorsson G, Bridger S, et al. Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease. Gastroenterology. 2000; 119: 15-22.
48. Elkjaer M, Burisch J, Voxen Hansen V, et al. A new rapid home test for faecal calprotectin in ulcerative colitis. Aliment Pharmacol Ther. 2011; 31: 323-330.
49. Lopez-Leon S, Janssens AC, Gonzalez-Zuloeta Ladd AM, et al. Meta-analyses of genetic studies on major depressive disorder. Mol Psychiatry. 2008; 13: 772-785.
50. Mathew CG,. New links to the pathogenesis of Crohn disease provided by genome-wide association scans. Nat Rev. 2008; 9: 9-14.
51. Krishnan V, Nestler EJ,. The molecular neurobiology of depression. Nature. 2008; 455: 894-902.
52. Walters P, Schofield P, Howard L, et al. The relationship between asthma and depression in primary care patients: a historical cohort and nested case control study. PloS ONE. 2010; 6: e20750.
53. Kehlet H, Jensen TS, Woolf CJ,. Persistent postsurgical pain: risk factors and prevention. Lancet. 2006; 367: 1618-1625.
54. Goodhand J, Rampton D,. Psychological stress and coping in IBD. Gut. 2008; 57: 1345-1347.
55. Agronin ME,. Personality and psychopathology in late life. Geriatrics. 1998; 53 (Suppl 1): S35-40.
56. Bruce TO,. Comorbid depression in rheumatoid arthritis: pathophysiology and clinical implications. Curr Psychiatry Rep. 2008; 10: 258-264.
57. Keefe FJ, Somers TJ,. Psychological approaches to understanding and treating arthritis pain. Nat Rev Rheumatol. 2010; 6: 210-216.
58. Vidal A, Gomez-Gil E, Sans M, et al. Health-related quality of life in inflammatory bowel disease patients: the role of psychopathology and personality. Inflamm Bowel Dis. 2008; 14: 977-983.
59. Hauser W, Schmidt C, Stallmach A,. Depression and mucosal proinflammatory cytokines are associated in patients with ulcerative colitis and pouchitis - a pilot study. J Crohns Colitis. 2011; 5: 350-353.
60. Dantzer R, O'Connor JC, Freund GG, et al. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci. 2008; 9: 46-56.
61. Andrews H, Barczak P, Allan RN,. Psychiatric illness in patients with inflammatory bowel disease. Gut. 1987; 28: 1600-1604.
62. Guthrie E, Jackson J, Shaffer J, et al. Psychological disorder and severity of inflammatory bowel disease predict health-related quality of life in ulcerative colitis and Crohn's disease. Am J Gastroenterol. 2002; 97: 1994-1999.
63. Nordin K, Pahlman L, Larsson K, et al. Health-related quality of life and psychological distress in a population-based sample of Swedish patients with inflammatory bowel disease. Scand J Gastroenterol. 2002; 37: 450-457.
64. Mikocka-Walus AA, Turnbull DA, Moulding NT, et al. Antidepressants and inflammatory bowel disease: a systematic review. Clin Pract Epidemol Ment Health. 2006; 2: 24.
65. Timmer A, Preiss JC, Motschall E, et al. Psychological interventions for treatment of inflammatory bowel disease. Cochrane Database Syst Rev. 2011; 2: CD006913.
66. Goodhand JR, Wahed M, Rampton DS,. Management of stress in inflammatory bowel disease: a therapeutic option? Expert Rev Gastroenterol Hepatol. 2009; 3: 661-679.